Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKBKB | O14920 | 8/20 | 0.49 |
| ▸ | CCND1 | P24385 | 10/20 | 0.45 |
| ▸ | CDK2 | P24941 | 10/20 | 0.45 |
| ▸ | CDK6 | Q00534 | 9/20 | 0.45 |
| ▸ | CCNE1 | P24864 | 8/20 | 0.45 |
| ▸ | CHUK | O15111 | 1/20 | 0.44 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.44 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.44 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.44 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.44 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.44 |
| ▸ | CDK4 | P11802 | 6/20 | 0.44 |
| ▸ | CCNT1 | O60563 | 3/20 | 0.44 |
| ▸ | CDK9 | P50750 | 3/20 | 0.44 |
| ▸ | CDK1 | P06493 | 3/20 | 0.43 |
| ▸ | CCNB1 | P14635 | 3/20 | 0.43 |
| ▸ | CCND3 | P30281 | 3/20 | 0.43 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.43 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.43 |
| ▸ | CDK7 | P50613 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL84374 | 0.86 | HRH4 (0.40) | IKBKBCCND1CDK2CDK6CCNE1 | |
| SCHEMBL84453 | 0.84 | IKBKB (0.54) | IKBKBCCND1CDK2CDK6CCNE1 | |
| SCHEMBL91448 | 0.84 | IKBKB (0.52) | IKBKBCCND1CDK2CDK6CCNE1 | |
| SCHEMBL83995 | 0.81 | CDK4 (0.47) | IKBKBCCND1CDK2CDK6CCNE1 | |
| SCHEMBL84414 | 0.79 | CDK1 (0.54) | CCND1CDK2CDK6CCNE1MAPK8 | |
| SCHEMBL14004978 | 0.78 | MAPK1 (0.57) | CCND1CDK2CDK6CCNE1MAPK8 | |
| SCHEMBL84078 | 0.77 | CDK1 (0.56) | CCND1CDK2CDK6CCNE1MAPK8 | |
| SCHEMBL14383122 | 0.75 | CDK4 (0.59) | IKBKBCCND1CDK2CDK6CCNE1 | |
| SCHEMBL84472 | 0.75 | JAK3 (0.44) | CDK2MAPK8MAPK9MAPK10 | |
| SCHEMBL29212025 | 0.73 | IKBKB (0.49) | IKBKBCCND1CDK2CDK6CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8865732-B2 | Heterocyclic compounds and uses thereof | NOVARTIS AG (CH) | 2014-10-21 | — | — | US | disclosed |
| US-20130210818-A1 | Novel Heterocyclic Compounds and Uses Thereof | NOVARTIS AG (CH) | 2013-08-15 | — | — | US | disclosed |
| US-8129394-B2 | Heteroaryl-substituted imidazole compounds and uses thereof | NOVARTIS AG (CH) | 2012-03-06 | — | — | US | disclosed |
| US-20100003246-A1 | Novel heterocyclic compounds and uses therof | NOVARTIS AG (CH) | 2010-01-07 | — | — | US | disclosed |
| US-20100003246-A1 | Novel heterocyclic compounds and uses therof | NOVARTIS AG (CH) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100003246-A1 | Novel heterocyclic compounds and uses therof | BRAF, ARAF, KRAS | IKBKB 541/4885CCND1 747/4885CDK2 20/4885 |
| US-20130210818-A1 | Novel Heterocyclic Compounds and Uses Thereof | BRAF, RAF1, HRAS | IKBKB 345/4885CCND1 919/4885CDK2 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.